Octapharma USA Inc
Octapharma USA Inc is a federal award recipient based in Paramus, NJ. The organization has received $5,500,000 in total federal obligations across 10 awards. Their primary industry classification is NAICS 325414.
Competitors in NAICS 325414
Other top federal contractors classified under the same primary NAICS code.
| Contractor | Location | Total Obligated |
|---|---|---|
| Glaxosmithkline, LLC | Research Triangle Park, NC | $980.5M |
| Emergent Product Development Gaithersburg Inc. | Gaithersburg, MD | $152.4M |
| Artemis Technologies Inc | Guelph | $8.1M |
| Boehringer Ingelheim Animal Health USA Inc | Duluth, GA | $7.6M |
| Boehringer Ingelheim Animal Health France | LYON | $5.5M |
| Biogenesis BAGO S.A. | Garin | $3.1M |
| Somalogic Operating CO., Inc | Boulder, CO | $3.1M |
| Versiti Blood Health, Inc. | Milwaukee, WI | $2.4M |
-
How much has Octapharma USA Inc received in federal contracts?
Octapharma USA Inc has received $5,500,000 in total federal contract obligations across 10 awards since 2000.
-
Which agencies work with Octapharma USA Inc?
Octapharma USA Inc works with 0 federal agencies. Their largest customer is N/A.
-
Is Octapharma USA Inc a small business?
Octapharma USA Inc does not currently hold small business certifications in the SAM.gov database.
-
What is Octapharma USA Inc's UEI number?
Octapharma USA Inc's Unique Entity Identifier (UEI) is FKJKNJVR1HV4 and their CAGE code is 484Y2.
Data sourced from USASpending.gov and SAM.gov . Federal contracting data is public domain.